210 related articles for article (PubMed ID: 14709069)
1. Establishing the parabolic relationship between reactivity and activity for derivatives and analogues of the duocarmycin and CC-1065 alkylation subunits.
Parrish JP; Hughes TV; Hwang I; Boger DL
J Am Chem Soc; 2004 Jan; 126(1):80-1. PubMed ID: 14709069
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of N-aryl and N-alkenyl CBI derivatives.
Parrish JP; Trzupek JD; Hughes TV; Hwang I; Boger DL
Bioorg Med Chem; 2004 Nov; 12(22):5845-56. PubMed ID: 15498660
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing cinnamoyl groups.
Nagamura S; Asai A; Amishiro N; Kobayashi E; Gomi K; Saito H
J Med Chem; 1997 Mar; 40(6):972-9. PubMed ID: 9083487
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, chemical properties, and biological evaluation of CC-1065 and duocarmycin analogues incorporating the 5-methoxycarbonyl-1,2,9,9a-tetrahydrocyclopropa.
Boger DL; Hughes TV; Hedrick MP
J Org Chem; 2001 Apr; 66(7):2207-16. PubMed ID: 11281757
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of a series of C3-substituted CBI analogues of CC-1065 and the duocarmycins.
Boger DL; Brunette SR; Garbaccio RM
J Org Chem; 2001 Jul; 66(15):5163-73. PubMed ID: 11463270
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, solvolytic stability and cytotoxicity of a modified derivative of CPzI, a pyrazole analog of the alkylation subunit of the antitumor agent CC-1065: effect of the nitrogen substitution on the functional reactivity.
Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Capolongo L; Cozzi P; Geroni C; Mongelli N
Farmaco; 1997 Dec; 52(12):717-23. PubMed ID: 9648275
[TBL] [Abstract][Full Text] [Related]
7. Site specific covalent alkylation of DNA by antitumor antibiotics, duocarmycin A and kapurimycin A3.
Sugiyama H; Lam CK; Hosoda M; Saito I
Nucleic Acids Symp Ser; 1991; (25):75-6. PubMed ID: 1842103
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
Amishiro N; Okamoto A; Murakata C; Tamaoki T; Okabe M; Saito H
J Med Chem; 1999 Jul; 42(15):2946-60. PubMed ID: 10425104
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of duocarmycin and CC-1065 analogues incorporating the 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]-3-azaindol-4-one (CBA) alkylation subunit.
Parrish JP; Kastrinsky DB; Hwang I; Boger DL
J Org Chem; 2003 Nov; 68(23):8984-90. PubMed ID: 14604371
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activity.
Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Cozzi P; Geroni C; Mongelli N
Farmaco; 1997 Dec; 52(12):711-6. PubMed ID: 9648274
[TBL] [Abstract][Full Text] [Related]
11. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
Isomura M; Sugiyama H; Saito I
Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
[TBL] [Abstract][Full Text] [Related]
12. A unique class of duocarmycin and CC-1065 analogues subject to reductive activation.
Jin W; Trzupek JD; Rayl TJ; Broward MA; Vielhauer GA; Weir SJ; Hwang I; Boger DL
J Am Chem Soc; 2007 Dec; 129(49):15391-7. PubMed ID: 18020335
[TBL] [Abstract][Full Text] [Related]
13. Solid-Phase Synthesis of Duocarmycin Analogues and the Effect of C-Terminal Substitution on Biological Activity.
Stephenson MJ; Howell LA; O'Connell MA; Fox KR; Adcock C; Kingston J; Sheldrake H; Pors K; Collingwood SP; Searcey M
J Org Chem; 2015 Oct; 80(19):9454-67. PubMed ID: 26356089
[TBL] [Abstract][Full Text] [Related]
14. Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
Boger DL; Stauffer F; Hedrick MP
Bioorg Med Chem Lett; 2001 Aug; 11(15):2021-4. PubMed ID: 11454471
[TBL] [Abstract][Full Text] [Related]
15. 1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogs of CC-1065 and the duocarmycins: synthesis and evaluation.
Boger DL; Yun W; Han N
Bioorg Med Chem; 1995 Nov; 3(11):1429-53. PubMed ID: 8634824
[TBL] [Abstract][Full Text] [Related]
16. Establishment of substituent effects in the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
Parrish JP; Kastrinsky DB; Stauffer F; Hedrick MP; Hwang I; Boger DL
Bioorg Med Chem; 2003 Aug; 11(17):3815-38. PubMed ID: 12901927
[TBL] [Abstract][Full Text] [Related]
17. CC-1065 analogues bearing different DNA-binding subunits: synthesis, antitumor activity, and preliminary toxicity study.
Wang Y; Li L; Ye W; Tian Z; Jiang W; Wang H; Wright SC; Larrick JW
J Med Chem; 2003 Feb; 46(4):634-7. PubMed ID: 12570384
[TBL] [Abstract][Full Text] [Related]
18. CC-1065/duocarmycin and bleomycin A2 hybrid agents: lack of enhancement of DNA alkylation by attachment to noncomplementary DNA binding subunits.
Boger DL; Han N
Bioorg Med Chem; 1997 Feb; 5(2):233-43. PubMed ID: 9061188
[TBL] [Abstract][Full Text] [Related]
19. Structural, Biochemical, and Computational Studies Reveal the Mechanism of Selective Aldehyde Dehydrogenase 1A1 Inhibition by Cytotoxic Duocarmycin Analogues.
Koch MF; Harteis S; Blank ID; Pestel G; Tietze LF; Ochsenfeld C; Schneider S; Sieber SA
Angew Chem Int Ed Engl; 2015 Nov; 54(46):13550-4. PubMed ID: 26373694
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of CBI-bearing ester and carbamate prodrugs of CC-1065 analogue.
Wang Y; Li L; Tian Z; Jiang W; Larrick JW
Bioorg Med Chem; 2006 Dec; 14(23):7854-61. PubMed ID: 16908174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
